SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SSgA Active Trust - SPDR S&P 500 ETF Trust

The SPY is trending as traders assess market volatility amidst concerns about regional banks and the potential for a trade war with China. Community discussions revolve around potential support levels and whether the market will experience a significant downturn or a bounce. Increasing VIX levels and rising gold prices add to the uncertain outlook, with some participants bracing for a potential market correction.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

RGTI is trending downwards as the community debates whether it's a scam or a buying opportunity, with some pointing to the CEO's past sale of shares as a negative signal. Discussions include potential price targets, upcoming earnings, and the overall valuation of the quantum computing sector. Bears anticipate a significant drop, while bulls hope for a rebound, contributing to the stock's volatility.

ZenaTech, Inc. is an enterprise software technology company, which specializes in mission-critical cloud-based applications integrated with smart hardware to deliver solutions across diverse industries. The firm also develops drone manufacturing, sales, and distribution business. The company was founded by Shaun A. Passley on August 31, 2017 and is headquartered in Vancouver, Canada.

ZenaTech Inc.

ZenaTech is trending due to its plans for congressional meetings to promote drone technology and US manufacturing, sparking community interest in its potential impact on securing funding and shaping policy. Community members are discussing the company's strong management, vision, and possible comparison to Droneshield's growth, while highlighting the increasing US government spending on defense drone contracts. The company's focus on AI drones in the growing defense sector is also a key talking point.

Bitfarms Ltd. (Canada) engages in the business of mining cryptocurrency. The firm is also involved in the ownership and operation of server farms comprised of computers designed for the purpose of validating transactions on the Bitcoin blockchain. The company was founded by Emiliano Joel Grodzki and Nicolas Bonta in 2017 and is headquartered in Toronto, Canada.

Bitfarms Ltd.

Bitfarms (BITF) is trending due to a recently announced offering of convertible senior notes, initially $300M then increased to $500M, intended to fund corporate needs and hedge against share dilution. While some investors express concerns about potential dilution and management decisions, others view the capital raise as a strategic move to fund expansion into AI and high-performance computing (HPC). The community is actively debating the offering's terms, potential impact, and the company's long-term prospects in the crypto mining and AI sectors.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is seeing increased volatility as traders weigh geopolitical concerns, banking sector jitters, and potential impacts from upcoming economic reports. Community members are actively discussing potential downside risks and hedging strategies, while also debating whether the current market dip presents a buying opportunity or signals a larger correction.

SPDR Gold Trust - SPDR Gold Shares ETF

SPDR Gold Shares ETF

GLD is trending as investors discuss gold's safe-haven appeal amid dollar concerns and potential bond market issues. The community is debating whether the rally is sustainable, with some predicting further gains while others foresee a significant correction. Broader economic factors, including U.S.-China trade dynamics and potential Federal Reserve actions, are also fueling the conversation.

Energy Fuels, Inc. is a mining development company, which engages in the exploration and evaluation of uranium and vanadium properties. It also operates the Nichols Ranch, Alta Mesa, and White Mesa Mill projects. The company was founded by George E. L. Glasier and John David Mason on June 24, 1987 and is headquartered in Lakewood, CO.

Energy Fuels Inc

Energy Fuels ($UUUU) is trending amidst discussions about its positioning in the rare earth element (REE) sector and potential government interest. Community members are weighing perspectives on the stock's valuation, recent price action, and the potential impact of U.S.-China trade dynamics on the REE market. The company's uranium assets and production capabilities are also being considered as factors influencing its future performance.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is trending as investors discuss the company's shift towards AI cloud infrastructure and a recently closed $1 billion convertible notes offering. Community members are weighing the potential impact of this transition and the large capital infusion on IREN's growth prospects, while others debate whether the stock is overvalued. Bullish sentiment remains, with many anticipating significant gains and increased institutional interest.

SharpLink Gaming, Inc. is an online performance-based marketing company, which engages in the provision of online platform facilitating sports betting. It connects sports fans, leagues, and sports websites to relevant and timely sports betting content. The company was founded by Robert Phythian in 2019 and is headquartered in Minneapolis, MN.

SharpLink Gaming Inc.

SharpLink Gaming Ltd

SBET is trending due to a recently priced share offering at a premium, signaling institutional confidence and sparking community discussion about the company's Ethereum strategy. Some investors are excited about the potential for future gains as the company continues to accumulate ETH, while others express concerns about dilution and management's performance relative to peers like BMNR. The stock's movements are closely tied to Ethereum's price, making it a subject of debate as crypto markets experience volatility.

Volatility Shares Trust - 2x Long VIX Futures ETF

Volatility Shares 2x Long VIX Futures ETF

UVIX is trending as traders discuss potential market volatility amidst concerns about trade tensions and economic uncertainty. Community members are actively debating whether to buy, sell, or hold, with some anticipating a significant market downturn while others express skepticism. The ETF's movements are being closely watched as a hedge against broader market risks.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Is IPF the Next Big Market Opportunity for United Therapeutics?

UTHR reports strong TETON-2 results for Tyvaso in IPF, showing lung function gains and eyeing a major new market.

UTHR Stock Hits Record High on Tyvaso Meeting IPF Study Goals

United Therapeutics hit a record high after its Tyvaso study in idiopathic pulmonary fibrosis met key goals and showed broad patient benefits.

Liquidia Technologies, Inc. (LQDA) Reports Q2 Loss, Beats Revenue Estimates

Liquidia Technologies (LQDA) delivered earnings and revenue surprises of -13.95% and +124.46%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Vericel Corporation (VCEL) Reports Q2 Loss, Lags Revenue Estimates

Vericel (VCEL) delivered earnings and revenue surprises of +75.00% and -1.33%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Liquidia Corp. saw heightened retail chatter Monday after Bank of America increased its stock price target to $25 from $22 while keeping a 'Buy' rating.The company identified the FDA approval of Yutrepia (treprostinil) inhalation powder as a significant advancement.Bank of America informed investors through a research note that Yurepia received approval as a substitute for United Therapeutics' (UTHR) Tyvaso.Liquidia closed down 1.35% at $15.35 on Friday but gained 2.87% after hours to $15.79.&nbsp;The regulatory framework dictates that Yutrepia's label closely matches Tyvaso, and Liquidia shares appear undervalued, considering their peak sales potential.The FDA approved Yutrepia on May 23 for adult patients with pulmonary arterial hypertension and pulmonary hypertension related to interstitial lung disease to enhance their exercise capacity.The company said that Yutrepia represents Liquidia's proprietary Print technology in its first dry-powder treprostinil formulation for deep-lung delivery through an inhalation device that requires minimal effort.The approval followed outcomes from the Phase 3 Inspire trial, which evaluated both treprostinil-naïve patients and individuals moving from nebulized treprostinil treatment.The research findings confirmed that Yutrepia demonstrated safety and tolerability for patients with no prior exposure to treprostinil and those who previously used it.According to Nicholas Hill, the principal investigator of the Inspire study, the device's low-effort inhalation feature could support treatment initiation and maintenance for patients with restricted lung function.On May 9, United Therapeutics initiated legal action in the U.S. District Court, claiming Liquidia's Yutrepia product launch would violate its U.S. Patent rights.United Therapeutics has filed a temporary restraining order and a preliminary injunction to prevent the product launch.&nbsp;Judges heard oral arguments on May 20, but the motion is still pending.Liquidia has expressed confidence in defending against the allegations, referencing the PTAB's prior invalidation of similar patents and subsequent affirmations by the courts.&nbsp;CEO Roger Jeffs said, "We are not surprised by UTHR’s repeated, last-minute attempts to deny PAH and PH-ILD patients access to an alternative therapy."On Stocktwits, retail sentiment was ‘extremely bullish’ amid an 80% surge in 24-hour message volume.One user argued that Yutrepia is likely to outperform Tyvaso DPI in treating PH-ILD, claiming that patients struggle with Tyvaso’s delivery method and often discontinue use due to side effects like coughing and dosing difficulties.&nbsp;They suggested that Yutrepia’s Print-powered formulation offers a smoother, more consistent experience and allows for easier dose escalation, adding that prescribers are aware of the differences and may shift away from Tyvaso DPI.&nbsp;<stembedurl>https://stocktwits.com/SiestaKey1/message/615871355</stembedurl>Another user said that while both drugs offer similar efficacy, the approval of Yutrepia gives patients and prescribers additional options.&nbsp;<stembedurl>https://stocktwits.com/Phantom_stocks51/message/615843447</stembedurl>The stock has risen 26.9% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Generic capsules, 25 July 2004. AFR Picture by LOUIE DOUVIS (Photo by Fairfax Media via Getty Images)

Liquidia Retail Buzz Surges After BofA Raises Price Target to $25 On Yutrepia FDA Nod

The company’s proprietary dry-powder formulation, supported by Phase 3 data, is viewed as a promising alternative to United Therapeutics’ Tyvaso, though legal challenges remain pending.

Equity

Liquidia Technologies, Inc. (LQDA) Reports Q1 Loss, Misses Revenue Estimates

Merus N.V. (MRUS) Reports Q1 Loss, Tops Revenue Estimates

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Liquidia Corporation - LQDA

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Liquidia Corporation - LQDA SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of...

Liquidia Corp. operates as a holding company which engages through its subsidiary in developing and commercializing biopharmaceutical products and novel products development used in PRINT technology to transform the lives of patients. The company was founded in June 2004 and is headquartered in Morrisville, NC.

Liquidia Corp

Will Netflix ($NFLX) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

Netflix Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '25	-$0.40	--	--	N/A
Q2 '25	-$0.42	-$0.49	-16.36%	MISSED
Q1 '25	-$0.40	-$0.45	-11.15%	MISSED
Q4 '24	-$0.37	-$0.45	-20.02%	MISSED
Q3 '24	-$0.37	-$0.30	19.72%	BEAT

LQDA
Liquidia Corp

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q3 '25

Historical Earnings

Latest LQDA News

LQDALiquidia Corp